Loading...
FINDEX Inc.
3649.T•JPX
Healthcare
Medical - Healthcare Information Services
¥752.00
¥6.00(0.80%)
FINDEX Inc. (3649.T) Financial Performance & Income Statement Overview
Review FINDEX Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
12.51%
↑ 12.51%
Operating Income Growth
1.93%
↑ 1.93%
Net Income Growth
9.75%
↑ 9.75%
Operating Cash Flow Growth
125.28%
↑ 125.28%
Operating Margin
26.23%
↑ 26.23%
Gross Margin
62.78%
↑ 62.78%
Net Profit Margin
19.37%
↑ 19.37%
ROE
19.84%
↑ 19.84%
ROIC
23.91%
↑ 23.91%
FINDEX Inc. (3649.T) Income Statement & Financial Overview
Review FINDEX Inc.'s (3649.T) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.53B | $1.10B | $1.08B | $2.12B |
| Cost of Revenue | $579.44M | $426.17M | $499.60M | $782.74M |
| Gross Profit | $951.75M | $678.50M | $581.34M | $1.34B |
| Gross Profit Ratio | $0.62 | $0.61 | $0.54 | $0.63 |
| R&D Expenses | $0.00 | $0.00 | $13.30M | $12.13M |
| SG&A Expenses | $537.61M | $493.23M | $489.81M | $467.55M |
| Operating Expenses | $551.98M | $493.23M | $503.12M | $479.69M |
| Total Costs & Expenses | $1.13B | $919.39M | $1.003B | $1.26B |
| Interest Income | $0.00 | $0.00 | $14000.00 | $25000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $10.35M | $11.30M | $71.98M | $69.75M |
| EBITDA | $410.13M | $196.57M | $151.83M | $862.14M |
| EBITDA Ratio | $0.27 | $0.18 | $0.14 | $0.41 |
| Operating Income | $399.77M | $185.27M | $78.23M | $862.15M |
| Operating Income Ratio | $0.26 | $0.17 | $0.07 | $0.41 |
| Other Income/Expenses (Net) | $10.14M | $2.19M | $1.62M | $3.38M |
| Income Before Tax | $409.92M | $187.47M | $79.85M | $865.53M |
| Income Before Tax Ratio | $0.27 | $0.17 | $0.07 | $0.41 |
| Income Tax Expense | $79.23M | $58.64M | $23.86M | $220.49M |
| Net Income | $330.74M | $130.30M | $58.38M | $642.94M |
| Net Income Ratio | $0.22 | $0.12 | $0.05 | $0.30 |
| EPS | $12.88 | $5.08 | $2.28 | $25.07 |
| Diluted EPS | $12.88 | $5.08 | $2.28 | $25.07 |
| Weighted Avg Shares Outstanding | $25.67M | $25.67M | $25.66M | $25.65M |
| Weighted Avg Shares Outstanding (Diluted) | $25.67M | $25.67M | $25.66M | $25.65M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan